The design of vaccines containing epitopes shared between different human pathogens may lead to cross-species protection. In order to identify potentially conserved bacterial antigens, bacteriophage expression libraries of genomic DNA from Streptococcus agalactiae, Streptococcus pneumoniae and Streptococcus pyogenes were probed with human sera from Staphylococcus aureus-infected and healthy individuals. By comparison with previous screening data from Staphylococcus epidermidis and Staph. aureus, putative antigenic, conserved domains across the genera were identified. In particular, three potentially antigenic conserved regions were identified based on the N-terminal domain of SACOL0609 (SdrD), the C-terminal domain of SACOL0723 (ScaB) and the C-terminus of SACOL1140 (IsdA) from Staph. aureus. The three domains were overexpressed, recombinant proteins were purified and polyclonal antisera raised against them recognized cell surface-located proteins from both staphylococcal and streptococcal species. The antisera were also able to opsonize both Staph. aureus and Strep. agalactiae thereby increasing their phagocytic uptake by human neutrophils. The conserved antigenic domains therefore represent potential cross-protective vaccine candidates.
INTRODUCTION
Staphylococci and streptococci are common agents of human infection. Staphylococcus aureus is a leading cause of nosocomial and community-acquired disease (Emori & Gaynes, 1993; Steinberg et al., 1996; Waldvogel, 1995) , causing thousands of deaths worldwide, each year (Diekema et al., 2001) . It is able to inhabit a wide range of tissues within the human body, resulting in infections from boils and abscesses to more life-threatening pathologies such as bacteraemia, septicaemia and endocarditis. The spread of antibiotic-resistant strains, in particular meticillin-resistant Staph. aureus (MRSA), has led to this being recognized as a significant clinical problem (Marchese et al., 2000) .
Staphylococcus epidermidis is also a common cause of nosocomial infections. Like Staph. aureus it is an inhabitant of human skin and is the most common organism causing infection of cerebrospinal fluid shunts and endocarditis of prosthetic valves and catheters (Giamarellou, 2002) .
Resistance to a wide range of antibiotics is common (Archer & Climo, 1994) .
Infection by the pathogen Streptococcus pneumoniae is a primary source of bacterial pneumonia, otitis media and meningitis, and is a common cause of sepsis in patients infected with human immunodeficiency virus. Strep. pneumoniae is capable of rapid acquisition and spread of antibiotic resistance; the number of reported antibioticresistant clinical isolates of this bacterium has increased dramatically over the last 20 years, and multi-resistant strains have already emerged (Mera et al., 2005) .
Streptococcus agalactiae, or group B streptococcus (GBS), is a commensal organism in adults that colonizes the rectum and urogenital and gastrointestinal tracts. However, Strep. agalactiae remains a leading cause of pneumonia, sepsis and meningitis in neonates, whereby infection is acquired during delivery by direct mother-to-baby transmission (Schuchat, 1999) . Despite the use of antibiotic therapy, GBS still causes hundreds of deaths annually. chronic, disease in varied locations throughout the body, including the skin (impetigo), the respiratory tract (pharyngitis) and deeper tissues (necrotizing fasciitis, rheumatic fever, rheumatic heart disease, glomerulonephritis, psoriasis, toxic-shock-like syndrome), and most recently has gained notoriety as the 'flesh-eating' bacterium which invades skin and soft tissues (Cunningham, 2000) .
The emergence of multiple antibiotic-resistant strains of these pathogens, or the limited effectiveness of antibiotic therapy in some cases, has led to the opinion that vaccination may be the most effective way to reduce the incidence of these infections in the long-term. The production of effective vaccines requires the identification of surface antigens that are both expressed during infection and recognized by the immune system. Previously, we have screened expression libraries of bacterial DNA with human sera to reveal in vivo expressed antigens Pourmand et al., 2006) . A range of potential vaccine candidates for Staph. aureus was found, including the surface protein IsdA, which was effective in vaccination against nasal carriage . Screening against a large collection of human sera revealed several infection-associated antigens from both Staph. aureus and Staph. epidermidis Pourmand et al., 2006) . A number of these are surface proteins from Staph. aureus, which have been found to be useful in a combination vaccine against the pathogen (Stranger-Jones et al., 2006) .
A previous study has revealed a novel family of surface proteins (Sca) in Staph. epidermidis, able to bind human ligands (Pourmand et al., 2006) . These proteins are matched by a homologous family in Staph. aureus, whose members have roles as peptidoglycan hydrolases (Heilmann et al., 2003 (Heilmann et al., , 2005 Layec et al., 2009; Eldholm et al., 2010) . Several Staph. aureus Sca proteins were also found to be antigens expressed during human infection . Thus conserved antigens across a range of species might be good candidates for prophylaxis against a number of organisms. However, the expected species coverage of such a vaccine requires the identification of targets and determination of their conservation within a diversity of organisms. In order to discover whether conserved antigens are present across several Gram-positive pathogens, a screening protocol involving sera from patients recovering from Staph. aureus infection was used to identify potentially conserved antigens in a range of species. This identified several protein domains, which were shown to be efficacious in opsonization experiments, highlighting their potential as vaccine candidates.
METHODS
Bacterial strains and plasmids. The strains and plasmids used in this study are listed in Table 1 . Escherichia coli was grown in LuriaBertani medium, using selection with ampicillin (100 mg ml 21 ) or kanamycin (50 mg ml 21 ) where appropriate. Staphylococcal and streptococcal strains were routinely grown in brain heart infusion For iron-limited conditions, Staph. aureus and Strep. agalactiae were grown in TSB (Oxoid), which had been treated with Chelex 100 resin (Sigma) followed by the addition of 10 mM dipyridyl and 0.4 mM MgSO 4 (Clarke et al., 2007) .
Construction of genomic expression libraries. Representative bacterial strains of different species were chosen for library construction. Libraries were made as previously described Pourmand et al., 2006; Tiyawisutsri et al., 2007 with Sau3A. The resulting 2-10 kb fragments were ligated into bacteriophage lambda DNA and packaged into phage particles using the Lambda ZAP Express kit (Stratagene) according to the manufacturer's instructions.
Human sera. Twenty-two sera were used to screen the genomic expression libraries. Of these, 16 were collected from individuals with Staph. aureus bacteraemia who were admitted to the Royal Hallamshire Hospital (Sheffield, UK). In all cases, Staph. aureus was the only proven microbiological aetiology of disease. The remaining 6 sera were collected from healthy community volunteers at the Royal Hallamshire Hospital. All individuals gave informed consent, and the study was approved by the local institutional review board (SSREEC/ 02/299).
Screening of the expression libraries with human sera. Libraries were screened as previously described (Pourmand et al., 2006) . Briefly, bacteriophages were propagated and plaque lifts were made onto Immobilon-NC membranes (Millipore) and probed with human sera diluted 1 : 1000, followed by alkaline phosphatase-conjugated antihuman IgG gamma chain specific monoclonal antibodies diluted 1 : 50 000 (Sigma). Further rounds of screening gave pure phages from which phagemids were excised.
In order to confirm cross-reactivity, Escherichia coli XLOLR containing excised phagemids was grown overnight in the presence of 10 mM IPTG. The cells were boiled in SDS-PAGE buffer and the proteins were separated by 17.5 % (w/v) SDS-PAGE, prior to Western blotting and probing with the appropriate human serum as previously described (Clarke et al., 2004) .
Phagemid DNA was purified and the resulting DNA was sequenced using primers T3 and T7. BLASTN searches using sequences from either end of the insert were carried out against the Strep. agalactiae NEM316, Strep. pneumoniae TIGR4 and Strep. pyogenes MGAS8232 genomic libraries (http://cmr.jcvi.org).
Bioinformatics. BLAST analysis was performed (http://www.jcvi.org/ cmr-blast) on the full length of the antigenic proteins identified in the genomic library screens of Staph. aureus, Staph. epidermidis, Strep. agalactiae, Strep. pneumoniae and Strep. pyogenes. All known or potentially surface-located antigens from Staph. aureus were analysed for regions of homology to potentially surface-located cross-reactive proteins from the Staph. epidermidis and streptococcal genomic libraries. Any sequences of ¢15 amino acids that showed at least 25 % sequence identity and 40 % sequence similarity (or 21-25 % identity in the case of .40 % similarity) were included to generate potential protein families.
Production of recombinant polypeptides and antisera. The fragments of the Staph. aureus genes, which represented conserved domains within the protein families, were amplified by PCR, using oligonucleotides BDF and BDR (SACOL0723), MS43 and MS44 (SACOL1140), and MS41 and MS42 (SACOL0609) ( Table 1 ). The resulting DNA fragments were cloned into pET21a or pET24d, and clones were verified by DNA sequencing. His 6 -tag recombinant polypeptides were overexpressed in E. coli BL21(DE3) following induction with 1 mM IPTG, and purified by binding to nickelcharged Hi-Trap Sepharose columns (Amersham) and eluting under a gradient of imidazole. The resulting recombinant polypeptides were dialysed against PBS before being injected into rabbits to raise polyclonal antisera. Pre-immune (naïve) sera were extracted from the rabbits immediately prior to injection of the polypeptide.
Opsonization of Staph. aureus and Strep. agalactiae. The opsonophagocytic activity of specific antisera was determined in an assay using Staph. aureus SH1000 and Strep. agalactiae 6313 in the presence of human neutrophils. Neutrophils were isolated from freshly obtained human blood. Baby rabbit serum (Cederlane Laboratories) was used as a complement source; any antibodies to Staph. aureus or Strep. agalactiae proteins were removed by incubating the serum with these strains for 30 min at 4 uC, followed by filter-sterilization. Bacteria were grown to exponential phase (OD 600~0 .5), and then washed and resuspended in PBS. 1610 5 bacteria were incubated with 2.5610 5 neutrophils, complement source (1 : 10 dilution) and specific antiserum or preimmune serum (1 : 10 dilution), to a final volume of 0.5 ml in RPMI. Immediately after mixing, a sample was taken for counting. Bacteria were enumerated by diluting in TSB containing 0.25 % (v/v) Tween 20 and plating onto BHI agar plates. The bacteria : neutrophil incubation was continued at 37 uC on a slow shaker for 90 min. A second sample was then removed and the numbers of bacteria were counted as before. The agar plates were incubated at 37 uC overnight and the percentage of bacteria remaining after 90 min was calculated. All experiments were carried out in triplicate.
RESULTS AND DISCUSSION

Identification of streptococcal cross-reactive antigens
Bacteriophage lambda expression libraries of Strep. agalactiae, Strep. pyogenes and Strep. pneumoniae were probed Tables 2, 3 and 4.
Identification of putative antigenic protein families
Previously, bacteriophage expression libraries of Staph. aureus and Staph. epidermidis were probed with sera in order to identify antigenic proteins Pourmand et al., 2006) . These studies, and our current results, have identified a wide range of potential antigens, many of unknown function. The previous data Pourmand et al., 2006) , together with those from the Strep. agalactiae, Strep. pyogenes and Strep. pneumoniae libraries, were subjected to in silico analysis in order to identify potential families of antigens, which might be conserved between Gram-positive pathogens.
BLAST analysis was employed to identify any homologous surface proteins identified in the screens of Staph. Alignments of the homologous sequences, with respect to each Staph. aureus antigen, were then made in order to identify any domains within the Staph. aureus proteins to which a significant number of cross-reactive proteins from other species showed homology. This identified the N-terminal domain (amino acids 30-200) of SACOL0609 ) and the C-terminal domain (amino acids 215-310) of SACOL1140 ) as the strongest potential conserved domains between these antigens (Figs 1 and 2). It is interesting that many of the proteins identified possess known or putative enzymic domains, such as glucosaminidase, amidase or cysteine, histidine-dependent amidohydrolases/peptidases (CHAP) domain, which are indicative of a role in cell wall autolytic activity and thus presumably exposure on the cell surface.
SdrD is a member of the multigene, serine-aspartate repeat family of proteins in Staph. aureus (Clarke & Foster, 2006) . It is an LPXTG motif surface protein that has been shown to bind calcium, although its role is as yet unclear (Josefsson et al., 1998a, b) . Interestingly, possession of the sdrD gene has been shown in some cases to be more frequent in MRSA than in MSSA strains (Sabat et al., 2006; Campbell et al., 2008) .
IsdA is a cell-surface protein containing a cell-wall sorting signal LPXTG motif, and has been suggested to function as a haem-binding protein of Staph. aureus (Vermeiren et al., 2006; Grigg et al., 2007) . It has been shown to be an ironregulated adhesin, which is able to bind to human serum, (Clarke et al., 2004 (Clarke et al., , 2009 Clarke & Foster, 2008; Corrigan et al., 2009) . Furthermore, it is also necessary for Staph. aureus nasal colonization in cotton rats, is effective in protection of rats against nasal carriage and is required for survival of Staph. aureus on human skin (Clarke et al., , 2007 . IsdA has two distinct functional domains. The N-terminal domain has a single copy of a NEAT domain, which is required for ligand binding activity and whose structure has been solved (Grigg et al., 2007) . The C-terminal domain renders the cells more hydrophilic, resulting in increased resistance to human skin fatty acids and antimicrobial peptides and is required for survival on human skin (Clarke et al., 2007) . Intriguingly, it is the Cterminal domain of IsdA that shares potential epitope conservation with proteins from other species.
Given that IsdA and SdrD are surface proteins that are linked to roles in the host-pathogen interaction, they could represent appropriate immunotherapy targets. Immunization with a combined vaccine containing IsdA, IsdB, SdrD and SdrE has already been shown to generate significant protective immunity against Staph. aureus infection in a (Fig. 3) . This C-terminal domain was therefore investigated further as a basis for cross-protection against staphylococcal and streptococcal strains. and anti-ScaB 156-265 antisera were used to opsonize Staph. aureus and Strep. agalactiae, and the subsequent killing of the bacteria following uptake by human neutrophils was assessed.
In the case of antisera raised against IsdA 215-310 , the bacteria were grown in iron-free media to allow the expression of iron-regulated genes, including IsdA (Clarke et al., 2004) .
Incubation of Staph. aureus with each of the specific antisera resulted in significant reductions in the number of bacteria recovered, when compared to incubation with no serum (P50.0001, 0.0003 and 0.0005 for SdrD and IsdA 215-310 , respectively) or with pre-immune serum (P50.0168, 0.0185 and 0.0192 for SdrD and IsdA 215-310 , respectively) (Fig. 4a) . Thus, antisera raised against each of the polypeptides were able to opsonize Staph. aureus for uptake by host immune cells.
Incubation of Strep. agalactiae with each of the antisera also resulted in a reduction in the number of bacteria recovered from the neutrophils (Fig. 4b) . This was significant for the IsdA 215-310 antisera when compared with both no serum (P50.0146) and with pre-immune serum (P50.0007), and was significant for the SdrD 30-200 and ScaB 156-265 antisera when compared with incubation with pre-immune serum (P50.0004 and 0.0005, respectively). This indicates that antisera raised against these antigenic polypeptides from Staph. aureus were also able to recognize and bind to Strep. agalactiae, and suggests that cross-reactive antigens have been correctly identified using this approach.
In this study, we have identified conserved domains within staphylococcal and streptococcal antigenic and cross-reactive proteins. These conserved antigenic domains therefore represent potential cross-protective vaccine candidates, and if employed in immunotherapy may provide a novel strategy for the control of both staphylococcal and streptococcal infections. A recent study showed that experimental infection of individuals with the commensal bacterium Neisseria lactamica can generate systemic and mucosal opsonophagocytic antibodies to Neisseria meningitidis (Evans et al., 2011) . While it remains unknown which antigenic components of N. lactamica are responsible for this phenomenon, it is clearly possible to generate antibodies in vivo, which might prevent infection by another organism. Of course a potential pitfall is that conserved antigens may be present in the commensal microflora and so such vaccination may lead to unforeseen ecological consequences. Our work provides the proof of concept for further studies to establish the veracity of the approach.
